498 related articles for article (PubMed ID: 15161866)
1. Progressive cone dystrophy associated with mutation in CNGB3.
Michaelides M; Aligianis IA; Ainsworth JR; Good P; Mollon JD; Maher ER; Moore AT; Hunt DM
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1975-82. PubMed ID: 15161866
[TBL] [Abstract][Full Text] [Related]
2. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.
Khan NW; Wissinger B; Kohl S; Sieving PA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762
[TBL] [Abstract][Full Text] [Related]
3. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy.
Thiadens AA; Roosing S; Collin RW; van Moll-Ramirez N; van Lith-Verhoeven JJ; van Schooneveld MJ; den Hollander AI; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
Ophthalmology; 2010 Apr; 117(4):825-30.e1. PubMed ID: 20079539
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing unveils a frameshift mutation in CNGB3 for cone dystrophy: A case report of an Indian family.
Gupta S; Chaurasia A; Pathak E; Mishra R; Chaudhry VN; Chaudhry P; Mukherjee A; Mutsuddi M
Medicine (Baltimore); 2017 Jul; 96(30):e7490. PubMed ID: 28746191
[TBL] [Abstract][Full Text] [Related]
6. Novel CNGA3 and CNGB3 mutations in two Pakistani families with achromatopsia.
Azam M; Collin RW; Shah ST; Shah AA; Khan MI; Hussain A; Sadeque A; Strom TM; Thiadens AA; Roosing S; den Hollander AI; Cremers FP; Qamar R
Mol Vis; 2010 Apr; 16():774-81. PubMed ID: 20454696
[TBL] [Abstract][Full Text] [Related]
7. Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.
Michaelides M; Wilkie SE; Jenkins S; Holder GE; Hunt DM; Moore AT; Webster AR
Ophthalmology; 2005 Aug; 112(8):1442-7. PubMed ID: 15953638
[TBL] [Abstract][Full Text] [Related]
8. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21.
Kohl S; Baumann B; Broghammer M; Jägle H; Sieving P; Kellner U; Spegal R; Anastasi M; Zrenner E; Sharpe LT; Wissinger B
Hum Mol Genet; 2000 Sep; 9(14):2107-16. PubMed ID: 10958649
[TBL] [Abstract][Full Text] [Related]
10. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia.
Kohl S; Varsanyi B; Antunes GA; Baumann B; Hoyng CB; Jägle H; Rosenberg T; Kellner U; Lorenz B; Salati R; Jurklies B; Farkas A; Andreasson S; Weleber RG; Jacobson SG; Rudolph G; Castellan C; Dollfus H; Legius E; Anastasi M; Bitoun P; Lev D; Sieving PA; Munier FL; Zrenner E; Sharpe LT; Cremers FP; Wissinger B
Eur J Hum Genet; 2005 Mar; 13(3):302-8. PubMed ID: 15657609
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic features of Hungarian achromatopsia patients.
Varsányi B; Wissinger B; Kohl S; Koeppen K; Farkas A
Mol Vis; 2005 Nov; 11():996-1001. PubMed ID: 16319819
[TBL] [Abstract][Full Text] [Related]
12. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
[TBL] [Abstract][Full Text] [Related]
13. Progressive cone dystrophy with deutan genotype and phenotype.
Scholl HP; Kremers J; Besch D; Zrenner E; Jägle H
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):183-91. PubMed ID: 16082559
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygous CNGA3 mutations (R436W, L633P) in a Japanese patient with congenital achromatopsia.
Goto-Omoto S; Hayashi T; Gekka T; Kubo A; Takeuchi T; Kitahara K
Vis Neurosci; 2006; 23(3-4):395-402. PubMed ID: 16961972
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of achromatopsia in Swedish patients with defined genotypes.
Eksandh L; Kohl S; Wissinger B
Ophthalmic Genet; 2002 Jun; 23(2):109-20. PubMed ID: 12187429
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic findings in patients with congenital cone dysfunction. Mutations in the CNGA3, CNGB3, or GNAT2 genes].
Kellner U; Wissinger B; Kohl S; Kraus H; Foerster MH
Ophthalmologe; 2004 Aug; 101(8):830-5. PubMed ID: 15459792
[TBL] [Abstract][Full Text] [Related]
17. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
[TBL] [Abstract][Full Text] [Related]
18. Oligocone trichromacy: clinical and molecular genetic investigations.
Andersen MK; Christoffersen NL; Sander B; Edmund C; Larsen M; Grau T; Wissinger B; Kohl S; Rosenberg T
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):89-95. PubMed ID: 19797231
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant cone dystrophy caused by a novel mutation in the GCAP1 gene (GUCA1A).
Jiang L; Katz BJ; Yang Z; Zhao Y; Faulkner N; Hu J; Baird J; Baehr W; Creel DJ; Zhang K
Mol Vis; 2005 Feb; 11():143-51. PubMed ID: 15735604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
